Viewing Study NCT03485950


Ignite Creation Date: 2025-12-24 @ 5:12 PM
Ignite Modification Date: 2026-01-18 @ 3:26 AM
Study NCT ID: NCT03485950
Status: COMPLETED
Last Update Posted: 2022-03-15
First Post: 2018-03-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Other Infectious Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Other infectious diseases View
None Febrile neutropenic adults with cancer View
None Ceftolozane-Tazobactam View
None Cefepime View
None Meropenem View
None Piperacillin/Tazobactam View